Lilly’s Symbyax Requires Prior Authorization Under Massachusetts Medicaid
This article was originally published in The Pink Sheet Daily
Executive Summary
Further drug list changes include prior authorization requirements for Schering-Plough’s Rebetol and Rebetron effective May 3. MassHealth will require prior authorization for J&J’s Duragesic and Purdue’s OxyContin beginning June 1.